Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: US - Clinical Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-1: US - Clinical Laboratory Testing Market by Test Type (%), 2016
Figure 4-2: US - Clinical Chemistry Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-3: US - Human & Tumor Genetics Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-4: US - Medical Microbiology & Cytology Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 4-5: US - Esoteric Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-1: US - Clinical laboratory Testing Market Segment by Laboratories (%), 2016
Figure 5-2: US - Hospital Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-3: US - Physician Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 5-4: US - Independent Laboratory Testing Market (Billion US$), 2016 & 2022
Figure 7-1: US - Population 65 Years and Above (Million), 2016 & 2060
Figure 7-2: US - Prevalence of Cancer (Million), 2014 & 2024.
Figure 7-3: US - Number of Closed M&A Deals in Lab Industry (2001-2013)
Figure 8-1: LabCorp - Net Revenue by Segment (%), 2015
Figure 8-2: LabCorp - Net Revenue by Geography (%), 2015
Figure 8-3: OPKO Health Inc. - Revenue by Geography (%), 2015
Figure 8-4: Sonic Healthcare - Revenue by Segment (%), 2016
Figure 8-5: Sonic Health - Revenue by Geography (%), 2016
Figure 8-6: Alere Inc. - Revenue by Segment (%), 2015
Figure 8-7: Alere Inc. - Revenue by Geography (%), 2015
Figure 8-8: Abbott - Net Sales by Segment (%), 2015
Figure 8-9: Abbott - Net Sales by Geography (%), 2015
Figure 8-10: Charles River Laboratories - Revenue by Segment (%), 2015
Figure 8-11: Charles River Laboratories - Revenue by Geography (%), 2015
Figure 8-12: Healthscope Ltd. - Revenue by Segment (%), 2016
Figure 8-13: Sanofi - Net Sales by Geography (%), 2015
Figure 8-14: Qiagen - Net Sales by Segment (%), 2015
Figure 8-15: Qiagen - Net Sales by Geography (%), 2015
 
List of Tables:

Table 6-1: US - Tuberculosis Incidences (2014 & 2015)
Table 6-2: US - Influenza Incidences (2013 & 2014)
Table 6-3: US - HIV/AIDS Incidences (2013 & 2014)
Table 6-4: US - Gonorrhea Incidences (2013, 2014 & 2015)
Table 6-5: US - Cirrhosis Incidences (2013 & 2014)
Table 6-6: US - Kidney Diseases Incidences (2013 & 2014)
Table 6-7: US - Cancer Incidences (2013, 2014 & 2015)
Table 8-1: LabCorp - Financials (Million US$), 2013, 2014 & 2015
Table 8-2: OPKO - Financials (Million US$), 2013, 2014 & 2015
Table 8-3: Sonic Healthcare - Financials, (Million US$), 2014, 2015 & 2016
Table 8-4: Quest Diagnostics - Financials, (Million US$), 2013, 2014 & 2015
Table 8-5: Alere Inc. - Financials (Million US$), 2013, 2014 & 2015
Table 8-6: Abbott - Financials (Million US$), 2013, 2014 & 2015
Table 8-7: Charles River Laboratories - Financials (Million US$), 2013, 2014 & 2015
Table 8-8: Healthscope Ltd. - Financials (Million US$), 2014, 2015 & 2016
Table 8-9: Sanofi - Financials (Million US$), 2013, 2014 & 2015
Table 8-10: Qiagen - Financials (Million US$), 2013, 2014 & 2015